2016 Pipeline of Ocular Pain Market Review

RnRMarketResearch.com adds “Ocular Pain Pipeline Review, H1, 2016” Market Research to its database, providing in-depth, high quality, transparent and market-driven, expert’s analysis.

In-detail Table of Contents of Ocular Pain Pipeline Market

Companies Involved in Therapeutics Development InSite Vision Incorporated, Kala Pharmaceuticals, Inc., Ocular Therapeutix, Inc., Reata Pharmaceuticals, Inc. and Sylentis S.A.U.

Drug profiles bromfenac sodium + dexamethasone acetate, dexamethasone acetate SR, difluprednate XR, ISV-303, ketorolac tromethamine, loteprednol etabonate, loteprednol etabonate next generation, NT-71, NT-72, omaveloxolone, RX-10045, Small Molecules to Block NaV1.7 Channel for Pain and Pruritus and SYL-1001

The report provides comprehensive information on the therapeutics under development for Ocular Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ocular Pain and features dormant and discontinued projects.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=531933 .

Scope for this research:

• The report provides a snapshot of the global therapeutic landscape of Ocular Pain
• The report reviews pipeline therapeutics for Ocular Pain by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Ocular Pain therapeutics and enlists all their major and minor projects
• The report assesses Ocular Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Ocular Pain

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Complete research report at http://www.rnrmarketresearch.com/ocular-pain-pipeline-review-h1-2016-market-report.html .

List of Figures:

• Number of Products under Development for Ocular Pain, H1 2016
• Number of Products under Development by Companies, H1 2016
• Comparative Analysis by Late Stage Development, H1 2016
• Comparative Analysis by Early Stage Products, H1 2016
• Assessment by Monotherapy Products, H1 2016
• Number of Products by Top 10 Targets, H1 2016
• Number of Products by Stage and Top 10 Targets, H1 2016
• Number of Products by Mechanism of Actions, H1 2016
• Number of Products by Stage and Mechanism of Actions, H1 2016
• Number of Products by Routes of Administration, H1 2016
• Number of Products by Stage and Routes of Administration, H1 2016
• Number of Products by Molecule Types, H1 2016
• Number of Products by Stage and Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.